Joint Damage Is Inhibited With Enbrel® (Etanercept) Plus Methotrexate In Patients With Early Active Rheumatoid Arthritis
Jun 19th 2008Drug InformationArthritis
Data presented recently show that 80% of patients with early active rheumatoid arthritis achieved radiographic remission (or non-progression defined as a change in TSS≤0.5) at one year when treated with Enbrel (etanercept) and methotrexate, compared to 59% when treated with methotrexate alone1.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
